Form 4: UiPath CEO Daniel Dines Reports Sale of 45,000 Shares Under Pre-Arranged 10b5-1 Plan
Insider Transaction Report
UiPath CEO and Chairman Daniel Dines filed a Form 4 disclosing the sale of 45,000 shares of Class A Common Stock on July 14, 2025, executed under a Rule 10b5-1 trading plan.
Summary
- Daniel Dines, the CEO and Chairman of UiPath, Inc., filed a Form 4 with the SEC.
- The filing reports the sale of 45,000 shares of UiPath Class A Common Stock.
- The transaction occurred on July 14, 2025.
- The shares were sold at an average price of $12.4354 per share, with the transaction prices ranging from $12.2400 to $12.5700.
- This sale was conducted in compliance with a qualified selling plan adopted by Mr. Dines pursuant to Rule 10b5-1.
- Following this transaction, Daniel Dines beneficially owns 5,148,376 shares indirectly through Ice Vulcan Holding Limited, 24,918,585 shares directly, and 240,000 shares indirectly by his spouse.
Sentiment
Score: 5
Explanation: Neutral. The document reports a pre-scheduled insider stock sale, which is a routine disclosure. While insider sales can sometimes be viewed negatively, the 10b5-1 plan mitigates immediate concerns, and the executive retains substantial ownership.
Positives
- The sale was executed under a Rule 10b5-1 plan, indicating a pre-scheduled transaction for personal financial management rather than a reaction to new material non-public information.
- Daniel Dines retains substantial beneficial ownership in UiPath, totaling 30,306,961 shares (5,148,376 indirect + 24,918,585 direct + 240,000 indirect by spouse) after the reported transaction, demonstrating continued alignment with shareholder interests.
Negatives
- An insider sale, even if pre-planned, can sometimes be perceived negatively by the market as it reduces the insider's direct stake in the company.
Risks
- Potential for negative market perception due to insider selling, despite the transaction being pre-planned under a Rule 10b5-1 plan.
Future Outlook
The document primarily reports an insider transaction and does not provide forward-looking statements or guidance regarding the company's financial performance or strategic direction.
Industry Context
This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide specific insights into broader industry trends or the competitive landscape within the Robotic Process Automation (RPA) sector. Insider sales, even under 10b5-1 plans, are common for executives managing personal finances and diversification.
Comparison to Industry Standards
- This document reports an insider stock transaction, which is a standard disclosure requirement for publicly traded companies across all industries.
- There are no specific financial results or operational metrics within this filing to compare against industry benchmarks or competitor performance.
- Insider selling under a 10b5-1 plan is a common and accepted practice among executives across various industries for personal financial planning and diversification, aligning with general corporate governance standards.
Stakeholder Impact
- Shareholders: May observe a reduction in direct insider ownership, though this is mitigated by the 10b5-1 plan and the CEO's continued substantial overall ownership in the company.
Key Dates
| Date | Description |
|---|---|
| 07/14/2025 | Date of reported transaction (sale of 45,000 Class A Common Stock shares by Daniel Dines). |
Recommendation
holdKeywords
UiPath, PATH, Daniel Dines, SEC Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Corporate Governance, Executive Compensation, Robotic Process Automation, RPA
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.